| This article has been cited by |
| 1 | | |
| Alan Talevi,Eduardo A. Castro,Luis E. Bruno-Blanch |
| .2012;()229 |
| [DOI] |
|
| 2 | Discovering Complex Relationships of Drugs over Distributed Knowledgebases | |
| Juan Li,Ranjana Sharma,Yan Bai |
| International Journal of Distributed Systems and Technologies.2014;5(1)22 |
| [DOI] |
|
| 3 | Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis | |
| Ting-Hong Ye,Fang-Fang Yang,Yong-Xia Zhu,Ya-Li Li,Qian Lei,Xue-Jiao Song,Yong Xia,Ying Xiong,Li-Dan Zhang,Ning-Yu Wang,Li-Feng Zhao,Hong-Feng Gou,Yong-Mei Xie,Sheng-Yong Yang,Luo-Ting Yu,Li Yang,Yu-Quan Wei |
| Cell Death & Disease.2017;8(1)e2534 |
| [DOI] |
|
| 4 | Clomipramine kills Trypanosoma brucei by apoptosis | |
| Jean Henrique de Silva Rodrigues,Jasmin Stein,Mariana Strauss,Héctor Walter Rivarola,Tânia Ueda-Nakamura,Celso Vataru Nakamura,Michael Duszenko |
| International Journal of Medical Microbiology.2016;306(4)196 |
| [DOI] |
|
| 5 | Medication Repurposing: New Uses for Old Drugs | |
| Irene Seunghyun Hong,Heather J Ipema,Michael P Gabay,Amy E Lodolce |
| Journal of Pharmacy Technology.2011;27(3)132 |
| [DOI] |
|
| 6 | Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma | |
| Yongxia Zhu,Tinghong Ye,Xi Yu,Qian Lei,Fangfang Yang,Yong Xia,Xuejiao Song,Li Liu,Hongxia Deng,Tiantao Gao,Cuiting Peng,Weiqiong Zuo,Ying Xiong,Lidan Zhang,Ningyu Wang,Lifeng Zhao,Yongmei Xie,Luoting Yu,Yuquan Wei |
| Scientific Reports.2016;6(1)132 |
| [DOI] |
|
| 7 | Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder | |
| Branka Petkovic,Srdan Kesic,Vesna Pešic |
| Current Pharmaceutical Design.2020;26(4)466 |
| [DOI] |
|
| 8 | Antituberculosis therapy for 2012 and beyond | |
| Michael Lauzardo,Charles A. Peloquin |
| Expert Opinion on Pharmacotherapy.2012;13(4)511 |
| [DOI] |
|
| 9 | Antituberculosis therapy for 2012 and beyond | |
| Michael J. Barratt,Donald E. Frail |
| Expert Opinion on Pharmacotherapy.2012;13(4)1 |
| [DOI] |
|
| 10 | Antituberculosis therapy for 2012 and beyond | |
| Donald E. Frail,Michael J. Barratt |
| Expert Opinion on Pharmacotherapy.2012;13(4)33 |
| [DOI] |
|
| 11 | Antituberculosis therapy for 2012 and beyond | |
| Juan Li,Ranjana Sharma,Yan Bai |
| Expert Opinion on Pharmacotherapy.2016;13(4)1572 |
| [DOI] |
|
